A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells

Fan,Min; Li,Xinying; Jiang,Wei; Huang,Yun; Li,Jingdong; Wang,Zhiming

doi:10.3892/etm.2013.933

A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells

Authors:
- Min Fan
- Xinying Li
- Wei Jiang
- Yun Huang
- Jingdong Li
- Zhiming Wang
View Affiliations

Affiliations: Department of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, P.R. China
Published online on: January 30, 2013 https://doi.org/10.3892/etm.2013.933
Pages: 1143-1146

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) is a newly identified non-coding RNA, which is highly thyroid-specific. Dramatic downregulation in thyroid cancers suggests its potential roles in the occurrence and development of thyroid tumors. The present study aimed to investigate the effects of PTCSC3 on the biological features of thyroid cancer cells and to explore its possible function as a competing endogenous RNA to bind with miRNAs. Constructs containing the long non-coding RNA, PTCSC3, were transfected into various thyroid cancer cell lines (BCPAP, FTC133 and 8505C). Cell growth, cell cycle transition and apoptosis were measured by MTT assay and flow cytometry. In silico analysis was performed to identify the binding site of PTCSC3 for target miRNAs. Additionally, detection of putative miRNA by quantitative reverse transcription-polymerase chain reaction (RT-PCR) in thyroid cancer cells transfected with PTCSC3 was determined to confirm the interaction. Following transfection with PTCSC3, all three thyroid cancer cells originating from various pathological types of thyroid cancers demonstrated significant growth inhibition, cell cycle arrest and increased apoptosis. The top 20 miRNAs to have a potential interaction with PTCSC3 were identified, out of which miR-574-5p was selected to further confirm the inverse correlation with PTCSC3 in thyroid cancer cells in vitro. In the present study, PTCSC3 as a tumor suppressor was investigated as a competing endogenous RNA for miR-574-5p.

View Figures

View References

1	Wang Y and Wang W: Increasing incidence of thyroid cancer in Shanghai, China, 1983–2007. Asia Pac J Public Health. Mar 16–2012.(Epub ahead of print).
2	Chen AY, Jemal A and Ward EM: Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer. 115:3801–3807. 2009.
3	Davies L and Welch HG: Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 295:2164–2167. 2006.
4	Li X, Abdel-Mageed AB and Kandil E: BRAF mutation in papillary thyroid carcinoma. Int J Clin Exp Med. 5:310–315. 2012.
5	Li X, Abdel-Mageed AB, Mondal D and Kandil E: The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers. Thyroid. Aug 13–2012.(Epub ahead of print).
6	Gudmundsson J, Sulem P, Gudbjartsson DF, et al: Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet. 41:460–464. 2009. View Article : Google Scholar
7	Gudmundsson J, Sulem P, Gudbjartsson DF, et al: Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet. 44:319–322. 2012. View Article : Google Scholar : PubMed/NCBI
8	Takahashi M, Saenko VA, Rogounovitch TI, et al: The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet. 19:2516–2523. 2010. View Article : Google Scholar : PubMed/NCBI
9	He H, Nagy R, Liyanarachchi S, et al: A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res. 69:625–631. 2009. View Article : Google Scholar : PubMed/NCBI
10	Jendrzejewski J, He H, Radomska HS, et al: The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc Natl Acad Sci U S A. 109:8646–8651. 2012. View Article : Google Scholar : PubMed/NCBI
11	Salmena L, Poliseno L, Tay Y, Kats L and Pandolfi PP: A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
12	McCarthy N: Regulatory RNA: layer by layer. Nat Rev Genet. 12:8042011.PubMed/NCBI
13	Li X, Wang Z, Liu J, Tang C, Duan C and Li C: Proteomic analysis of differentially expressed proteins in normal human thyroid cells transfected with PPFP. Endocr Relat Cancer. 19:681–694. 2012. View Article : Google Scholar : PubMed/NCBI
14	Kertesz M, Iovino N, Unnerstall U, Gaul U and Segal E: The role of site accessibility in microRNA target recognition. Nat Genet. 39:1278–1284. 2007. View Article : Google Scholar : PubMed/NCBI
15	Liao JM and Lu H: Autoregulatory suppression of c-Myc by miR-185-3p. J Biol Chem. 286:33901–33909. 2011. View Article : Google Scholar : PubMed/NCBI
16	Mohammad F, Pandey GK, Mondal T, et al: Long noncoding RNA-mediated maintenance of DNA methylation and transcriptional gene silencing. Development. 139:2792–2803. 2012. View Article : Google Scholar : PubMed/NCBI
17	Cesana M, Cacchiarelli D, Legnini I, et al: A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
18	Kogo R, Shimamura T, Mimori K, et al: Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
19	Krzyzanowski PM, Muro EM and Andrade-Navarro MA: Computational approaches to discovering noncoding RNA. Wiley Interdiscip Rev RNA. 3:567–579. 2012. View Article : Google Scholar : PubMed/NCBI
20	Meyers-Needham M, Ponnusamy S, Gencer S, et al: Concerted functions of HDAC1 and microRNA-574-5p repress alternatively spliced ceramide synthase 1 expression in human cancer cells. EMBO Mol Med. 4:78–92. 2012. View Article : Google Scholar : PubMed/NCBI
21	Ranade AR, Cherba D, Sridhar S, et al: MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer. J Thorac Oncol. 5:1273–1278. 2010.
22	Ji S, Ye G, Zhang J, et al: miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer. Gut. April 5–2012.(Epub ahead of print).